Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.T&Cs apply
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.T&Cs apply
Vectus Biosystems Limited (VBS) is developing treatments for fibrosis, including for three of the largest diseases in the fibrotic market, namely heart, kidney and liver diseases. Funds from the IPO and from two subsequent fundraisings were used predominantly to develop the Company's lead compound, VB0004, which aims to treat the hardening of functional tissue and high blood pressure.
Find out what a historical investment in Vectus Biosystems Limited would be worth today using our VBS stock calculator.
Market Capitalisation
$6M
Price-earnings ratio
-2.69
Dividend yield
-
High today
$0.12
Low today
$0.09
Open price
$0.09
52-week high
$0.46
52-week low
$0.04
Ready to start your investing journey with Stake?
Open an accountThis is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in VBS on Stake
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
VBS related stocks